Seattle Genetics, Inc. (SGEN) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET
Company Participants
Peggy Pinkston - Vice President, Investor Relations
Clay Siegall - President and Chief Executive Officer
Chip Romp - Executive Vice President, Commercial, U.S.
Todd Simpson - Chief Financial Officer
Roger Dansey - Chief Medical Officer
Conference Call Participants
Michael Schmidt - Guggenheim
Salveen Richter - Goldman Sachs
Cory Kasimov - JPMorgan
Kenan McKay - RBC Capital Markets
Chad Messer - Needham & Company
Peter Kim - Barclays
Andrew Berens - SVB Leerink
Jay Olson - Oppenheimer
Greg Harrison - Bank of America
Andy Hsieh - William Blair
George Farmer - BMO Capital Markets
Reni Benjamin - JMP Securities
Joe Catanzaro - Piper Sandler
Operator
Good day and welcome to the Seattle Genetics Second Quarter 2020 Financial Results Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Ms. Peggy Pinkston, Vice President, Investor Relations. Please go ahead.
Peggy Pinkston
Thank you, operator and good afternoon everyone. I would like to welcome all of you to Seattle Genetics’ second quarter 2020 financial results conference call. With me today are Clay Siegall, President and Chief Executive Officer; Chip Romp, Executive Vice President, Commercial, U.S.; Todd Simpson, Chief Financial Officer; and Roger Dansey, Chief Medical Officer. Accompanying today’s conference call are supporting slides, which you will find on our website in the Investors section, Events and Presentations page. Following our prepared remarks, we will open the line for questions. We aim to keep this call to 1 hour and so ask that you limit yourself to one question to give everyone an opportunity to participate in Q&A during our call today.
Today’s conference call will include forward-looking statements regarding future or anticipated events and results, including the company’s
- Read more current SGEN analysis and news
- View all earnings call transcripts